Appointment of a new member of the Management Board / Early extension of CEO´s contract

aap Implantate AG, a medical technology company listed in the Prime Standard segment of the Frankfurt Stock Exchange, has strengthened its top management level. Today, the Supervisory Board has appointed Marek Hahn with effect from April 1st as a new member of the Management Board for the period April 1st until December 31st, 2012. Alongside Mr. Biense Visser (CEO) and Mr. Bruke Seyoum Alemu (COO), Mr. Hahn, as Chief Finance Officer (CFO), will be in charge of the divisions Finance, IT, Human Resources and Administration. Also, the contract of Mr. Visser has been extended early for another two years until the 31st of December 2012.

Since April 2007, Mr. Hahn (35) has been serving as Director of Finance for aap. Prior to that, he worked for many years for KPMG Deutsche Treuhandgesellschaft AG in the field of Auditing, Accounting and Executive Consulting in various positions in Germany and foreign countries. Mr. Hahn possesses comprehensive knowledge in the area of Finance and Controlling.

Rubino di Girolamo – Chairman of the Supervisory Board: “We are glad to have accomplished the early extension of Mr. Visser´s contract. Being a very successful manager and a company leader for many years, Mr. Visser will manage, together with the extended Management team, the company’s fortune in the future. With Mr. Hahn, aap was able to bind a Finance expert. With these decisions, aap was able to accomplish important pre-conditions to achieve the goal of a sustainable profitable growth as well as to develop aap to become an innovative product leader.”